DIABETES TECHNOLOGY SOCIETY PUBLISHES THE MOST COMPREHENSIVE REPORT CHARACTERIZING THE RELATIONSHIP BETWEEN DIABETES AND COVID-19
January 22, 2021 – Burlingame, CA – Diabetes Technology Society (DTS) announced today the publication in Journal of Diabetes Science and Technology of a comprehensive report detailing the relationship between diabetes and COVID-19. The report is a summary of the Virtual International COVID-19 and Diabetes Summit, which took place on August 26-27, 2020 and featured 79 speakers from six continents, representing NIH, CDC, ADA, medical schools, universities, consulting groups, and manufacturers.
This freely-accessible comprehensive 37-page report describes what is currently known about diabetes and COVID-19 and what needs to be done to protect people with diabetes from COVID-19 in the future. The summit highlighted areas of collaboration between experts in medicine, government, and industry to minimize the risks associated with diabetes and COVID-19 by applying effective clinical practice and emerging technology.
DTS is an educational organization devoted to the development and use of technology for people with diabetes. The official journal of DTS is Journal of Diabetes Science and Technology, which is the world’s largest journal focused on diabetes technology. DTS presents the Diabetes Technology Meeting and the Hospital Diabetes Meeting, and developed, with FDA input, the world’s first consensus cybersecurity standard with performance and assurance requirements for any medical device, which was DTSec for connected diabetes devices.